PALO ALTO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel ...
Device manufacturers may soon have access to a new framework for marketing and selling medical devices in the United Kingdom. On May 21, 2024, the UK Medicines and Healthcare products Regulatory ...
An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). This marks the first time a needle-free ...
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapy Highly experienced team ready to support ATMP innovators at all stages Offering comprehensive range of ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved leniolisib phosphate (Joenja) for treating adults and adolescents aged 12 years and older weighing 45 kg or more with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback